17h
Zacks Investment Research on MSNHere's Why You Should Retain DexCom Stock in Your Portfolio for NowDexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A strong ...
The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
In contrast, DexCom shares fell by 0.73%, a more moderate decline than broader market trends. As the company moves forward, its reaffirmation of a positive growth outlook for 2025 could provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results